EXAS EXACT Sciences Corporation gains 26% Jun 22, 2018

Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.http://www.priceseries.com/trade/EXAS-EXACT-Sciences-Corporation-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2018052920180622.html